Inhibition of SLC40A1 represses osteoblast formation via inducing iron accumulation and activating the PERK/ATF4/CHOP pathway mediated oxidative stress

  • 0Department of Orthopedics, Medical Affairs Department, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People's Republic of China.

|

|

Summary

This summary is machine-generated.

Solute carrier family 40 member 1 (SLC40A1) inhibition impairs osteoblast formation by increasing iron accumulation and oxidative stress via the PERK/ATF4/CHOP pathway. Restoring SLC40A1 promotes osteoblast differentiation and reduces oxidative stress.

Area Of Science

  • Biochemistry
  • Cell Biology
  • Bone Biology

Background

  • Osteoblast differentiation is crucial for bone health.
  • Iron metabolism and oxidative stress play significant roles in cellular processes.
  • The role of Solute Carrier Family 40 Member 1 (SLC40A1) in osteoblasts requires further elucidation.

Purpose Of The Study

  • To investigate the impact of SLC40A1 on iron accumulation, oxidative stress, and osteoblast differentiation.
  • To explore the underlying molecular mechanisms, including the PERK/ATF4/CHOP pathway.

Main Methods

  • Mouse preosteoblastic MC3T3-E1 cells were utilized.
  • Cells were transfected with SLC40A1 overexpression vectors (oeSLC40A1) or small interfering RNA (siSLC40A1).
  • Cell differentiation was induced, and treatments included ferrostatin-1 and GSK2606414.

Main Results

  • SLC40A1 inhibition (siSLC40A1) increased iron (Fe2+), malondialdehyde (MDA), and reactive oxygen species (ROS), while decreasing the glutathione (GSH)/oxidized glutathione (GSSG) ratio.
  • SLC40A1 overexpression (oeSLC40A1) reversed these effects.
  • Osteoblast differentiation markers (ALP, ARS, OPN, BMP2) were reduced by siSLC40A1 and increased by oeSLC40A1.
  • SLC40A1 negatively regulated the PERK/ATF4/CHOP pathway, which was implicated in the observed iron accumulation and oxidative stress.

Conclusions

  • SLC40A1 inhibition suppresses osteoblast formation.
  • This suppression is mediated by increased iron accumulation and PERK/ATF4/CHOP pathway-driven oxidative stress.
  • Targeting SLC40A1 and related pathways offers potential therapeutic strategies for bone disorders.

Related Concept Videos

Osteoclasts in Bone Remodeling 01:31

2.8K

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Necrosis 01:16

4.3K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

The Electron Transport Chain 01:30

16.1K

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

Regulation of the Unfolded Protein Response 01:31

2.4K

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...

PI3K/mTOR/AKT Signaling Pathway 01:22

3.4K

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...